Adjunctive rifampin therapy for diabetic foot osteomyelitis: A protocol for systematic review and meta-analysis
Conclusion:
This systematic review and meta-analysis will provide a comprehensive summary and careful evaluation of rifampicin as an adjuvant treatment of DFO with a view to providing multiple options for clinical treatment of the disease.
Registration number:
is INPLASY202040084.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: Antibiotic Therapy | China Health | Databases & Libraries | Diabetes | Diabetic Ulcers | Endocrinology | Internal Medicine | Osteomyelitis | Science | Statistics | Study